Cochlear Ltd has just recorded 5 consecutive down weeks. Since 2000, the 11-week forward interval following this type of persistent weakness is unblemished. 11-week average return 10.30%, win rate 15 from 15, standard deviation 6.39%, median 11.45%, maximum 23.32%, minimum 2.24%.
Interestingly, looking at the in-sample data of this particular setup, of the 165-weeks at risk (15 events x 11-weeks), 78.79% of all event weeks (130-weeks /165-weeks)
recorded a positive outcome up to and including the 11-week optimal outlook period.
Disclaimer: This data is not financial advice. Past performance is not a guide to future performance and may not be repeated. Past performance does not diminish the risk expectancy of any strategy. By its very nature ‘risk’ means you could and most likely will experience losses. No representation or warranty is given as to the accuracy or completeness of any information provided. Data is for educational and informational purposes only.
Interestingly, looking at the in-sample data of this particular setup, of the 165-weeks at risk (15 events x 11-weeks), 78.79% of all event weeks (130-weeks /165-weeks)
recorded a positive outcome up to and including the 11-week optimal outlook period.
Disclaimer: This data is not financial advice. Past performance is not a guide to future performance and may not be repeated. Past performance does not diminish the risk expectancy of any strategy. By its very nature ‘risk’ means you could and most likely will experience losses. No representation or warranty is given as to the accuracy or completeness of any information provided. Data is for educational and informational purposes only.